Xspray Pharma AB (publ)
STO: XSPRAY.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Per Andersson
- Employees
- 27
- Headquarters
- Solna, Sweden
- IPO year
- 2017
- Market cap
- SEK 1.0B
- Website
- https://www.xspraypharma.com
Loading XSPRAY…
Loading profile data…Frequently asked questions about XSPRAY
What does Xspray Pharma AB (publ) (XSPRAY.ST) do?
Xspray Pharma AB (publ), a pharmaceutical company, develops protein kinase inhibitors for targeted cancer treatments in Sweden. Its product candidates include HyNap-Nilo for the treatment of chronic myeloid leukemia; HyNap-Sora for the treatment of renal cancer and liver cancer, as well as several forms of thyroid cancer; and HyNap-Dasa for the...
Where does XSPRAY.ST trade?
Xspray Pharma AB (publ) (XSPRAY.ST) trades on the Stockholm Stock Exchange.
What sector is XSPRAY.ST in?
Xspray Pharma AB (publ) (XSPRAY.ST) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Xspray Pharma AB (publ)?
Per Andersson is the chief executive officer of Xspray Pharma AB (publ) (XSPRAY.ST).
Where is Xspray Pharma AB (publ) headquartered?
Xspray Pharma AB (publ) is headquartered in Sweden.
Does XSPRAY.ST pay a dividend?
Xspray Pharma AB (publ) (XSPRAY.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XSPRAY.ST go public?
Xspray Pharma AB (publ) (XSPRAY.ST) completed its initial public offering in 2017.